Diverse targets of β-catenin during the epithelial-mesenchymal transition define cancer stem cells and predict disease relapse

Cancer Research

Volumn 75, Issue 16, 2015, Pages 3398-3410

  Chang, Yi Wen ^a   Su, Ying Jhen ^a   Hsiao, Michael ^b   Wei, Kuo Chen ^c   Lin, Wei Hsin ^a,d   Liang, Chi Lung ^a   Chen, Shin Cheh ^c   Lee, Jia Lin ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CASPASE 3; CD133 ANTIGEN; PROTEIN SOX15; T CELL FACTOR 4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; NUCLEAR PROTEIN; PEPTIDE; PROTEIN BINDING; SOX15 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

ABCG2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENICITY; CASP3 GENE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CLEAVAGE; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; ANIMAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE; TUMOR RECURRENCE; WESTERN BLOTTING; WNT SIGNALING PATHWAY; XENOGRAFT;

ANIMALS; ANTIGENS, CD; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE, SCID; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PROTEIN BINDING; SOX TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TWIST TRANSCRIPTION FACTOR; WNT SIGNALING PATHWAY;

EID: 84942885232     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3265     Document Type: Article

References (49)

1. Mani SA, Guo W, Liao M.J., Eaton EN, Ayyanan A, Zhou AY, et al The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-15.
2. Scheel C, Eaton EN, Li S.H., Chaffer CL, Reinhardt F, Kah KJ, et al Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011; 145: 926-40.
3. Thiery JP, Sleeman JP Complex networks orchestrate epithelial-mesen-chymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-42.
4. Yang MH, Hsu DS, Wang H.W., Wang HJ, Lan HY, Yang WH, et al Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010; 12: 982-92.
5. Chung MT, Lai HC, Sytwu H.K., Yan MD, Shih YL, Chang CC, et al SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol 2009; 112: 646-53.
6. Shiota M, Izumi H, Tanimoto A., Takahashi M, Miyamoto N, Kashiwagi E., et al. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Res 2009; 69: 3148-56.
7. Demontis S, Rigo C, Piccinin S., Mizzau M, Sonego M, Fabris M., et al. Twist is substrate for caspase cleavage and proteasome-mediated degradation. Cell Death Differ 2006; 13: 335-45.
8. Lee JL, Chang CJ, Wu S.Y., Sargan DR, Lin CT. Secreted frizzled-related protein 2 (SFRP2) is highly expressed in canine mammary gland tumors but not in normal mammary glands. Breast Cancer Res Treat 2004; 84: 139-49.
9. Su YJ, Lai HM, Chang Y.W., Chen GY, Lee JL. Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 2011; 30: 3186-99.
10. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-60.
11. Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 1994; 2:28-36.
12. Machanick P, Bailey TL. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 2011; 27: 1696-7.
13. Bardet AF, He Q, Zeitlinger J., Stark A. A computational pipeline for comparative ChIP-seq analyses. Nat Protoc 2012; 7: 45-61.
14. Portales-Casamar E., Thongjuea S, Kwon A.T., Arenillas D., Zhao X, Valen E, et al JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res 2010; 38: D105-10.
15. Robasky K, Bulyk ML UniPROBE, update 2011: expanded content and search tools in the online database of protein-binding microarray data on protein-DNA interactions. Nucleic Acids Res 2011; 39: D124-8.
16. Lee JL, Wang MJ, Chen JY Acetylation and activation of STAT3 mediated by nuclear translocation of CD44. J Cell Biol 2009; 185: 949-57.
17. Chen XF, Zhang HT, Qi Q.Y., Sun MM, Tao LY. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Lung Cancer 2005; 48: 69-76.
18. Lee JL, Lin CT, Chueh L.L., Chang CJ. Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis: a possible mechanism of mammary tumorigenesis. J Biol Chem 2004; 279: 14602-9.
19. Miettinen PJ, Ebner R, Lopez A.R., Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127: 2021-36.
20. Wu Y, Ginther C, Kim J., Mosher N, Chung S, Slamon D., et al. Expression of Wnt3 activates Wnt/beta-catenin pathway and promotes EMT-like pheno-type in trastuzumab-resistant HER2-overexpressing breast cancer cells. Mol Cancer Res 2012; 10: 1597-606.
21. Kanzawa M, Semba S, Hara S., Itoh T, Yokozaki H. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells. Pathobiology 2013; 80: 235-44.
22. Hamada S, Satoh K, Hirota M., Kimura K, Kanno A, Masamune A, et al. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J Cell Physiol 2007; 213:768-74.
23. Chikazawa N, Tanaka H, Tasaka T, Nakamura M, Tanaka M, Onishi H, et al. Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. Anticancer Res 2010; 30: 2041-8.
24. van de Wetering M, Oosterwegel M, Dooijes D, Clevers H. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J 1991; 10: 123-32.
25. Chu YW, Yang PC, Yang S.C., Shyu YC, Hendrix MJ, Wu R, et al Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997; 17: 353-60.
26. Camp RL, Rimm EB, Rimm DL Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 1999; 86: 2259-65.
27. Pirozzi G, Tirino V, Camerlingo R., Franco R, La Rocca A, Liguori E, et al Epithelial to mesenchymal transition by TGFbeta-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS One 2011; 6: e21548.
28. Sierra J, Yoshida T, Joazeiro C.A., Jones KA. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 2006; 20: 586-600.
29. Noordermeer J, Klingensmith J, Perrimon N., Nusse R. dishevelled and armadillo act in the wingless signalling pathway in Drosophila. Nature 1994; 367: 80-3.
30. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, PerryWL III, et al. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997; 90: 181-92.
31. Groden J, Thliveris A, Samowitz W., Carlson M, Gelbert L, Albertsen H., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
32. He X, Saint-Jeannet JP, Woodgett J.R., Varmus HE, Dawid IB. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature 1995; 374: 617-22.
33. Kimelman D, Xu W. beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 2006; 25: 7482-91.
34. Spiegelman VS, Slaga TJ, Pagano M, Minamoto T., Ronai Z, Fuchs SY. Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. Mol Cell 2000; 5: 877-82.
35. Hart M, Concordet JP, Lassot I, Albert I., del los Santos R, Durand H, et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999; 9: 207-10.
36. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86: 391-9.
37. Morin PJ. beta-catenin signaling and cancer. Bioessays 1999; 21: 1021-30.
38. Seidensticker MJ, Behrens J. Biochemical interactions in the wnt pathway. Biochim Biophys Acta 2000; 1495: 168-82.
39. Li VS, Ng SS, Boersema P.J., Low TY, Karthaus WR, Gerlach JP, et al Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 2012; 149: 1245-56.
40. Orford K, Crockett C, Jensen J.P., Weissman AM, Byers SW. Serine phos-phorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 1997; 272: 24735-8.
41. Huang P, Senga T, Hamaguchi M. A novel role of phospho-beta-catenin in microtubule regrowth at centrosome. Oncogene 2007; 26: 4357-71.
42. Chilov D, Sinjushina N, Rita H., Taketo MM, Makela TP, Partanen J. Phosphorylated beta-catenin localizes to centrosomes of neuronal progenitors and is required for cell polarity and neurogenesis in developing midbrain. Dev Biol 2011; 357: 259-68.
43. Sadot E, Conacci-Sorrell M, Zhurinsky J., Shnizer D, Lando Z, Zharhary D., et al. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci 2002; 115: 2771-80.
44. Fujita J, Crane AM, Souza M.K., Dejosez M., Kyba M, Flavell RA, et al Caspase activity mediates the differentiation ofembryonic stem cells. Cell Stem Cell 2008; 2: 595-601.
45. Levkau B, Koyama H, Raines E.W., Clurman BE, Herren B, Orth K, et al Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell 1998; 1: 553-63.
46. Liu L, Zhu XD, Wang W.Q., Shen Y., Qin Y, Ren ZG, et al Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res 2010; 16: 2740-50.
47. Gomez I, Pena C, Herrera M., Munoz C, Larriba MJ, Garcia V, et al TWIST1 is expressed in colorectal carcinomas and predicts patient survival. PLoS One 2011; 6: e18023.
48. Du YC, Oshima H, Oguma K., Kitamura T, Itadani H, Fujimura T., et al. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis. Gastroenterology 2009; 137: 1346-57.
49. Qin YR, Tang H, Xie F., Liu H, Zhu Y, Ai J., et al. Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. Clin Cancer Res 2011; 17: 46-55.